Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00096265

Public ClinicalTrials.gov record NCT00096265. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase III trial is studying whole-brain radiation therapy and stereotactic radiosurgery with or without temozolomide or erlotinib to see how well they work compared to whole-brain radiation therapy and stereotactic radiosurgery in treating patients with brain metastases secondary to non-small cell lung cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Stereotactic radiosurgery may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop tumor cells from dividing so they stop growing or die. Erlotinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth and by blocking blood flow to the tumor. It is not yet known whether radiation therapy and stereotactic radiosurgery are more effective with or without temozolomide or erlotinib in treating brain metastases.

Study identification

NCT ID
NCT00096265
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
126 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 6, 2004 (Actual)
Primary completion
Jun 14, 2011 (Actual)
Completion
Apr 1, 2012 (Actual)
Last update posted
Mar 9, 2018

2004 – 2012

United States locations

U.S. sites
80
U.S. states
30
U.S. cities
70
Facility City State ZIP Site status
Arizona Oncology Services Foundation Scottsdale Arizona 85260 —
Scottsdale Health Care-Osborn Scottsdale Arizona 85260 —
Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank California 91505 —
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027 —
Pomona Valley Hospital Medical Center Pomona California 91767 —
Saint Mary's Hospital and Regional Medical Center Grand Junction Colorado 81501 —
Christiana Care Health System-Christiana Hospital Newark Delaware 19718 —
Baptist MD Anderson Cancer Center Jacksonville Florida 32207 —
Integrated Community Oncology Network-Southside Cancer Center Jacksonville Florida 32207 —
Baptist Medical Center South Jacksonville Florida 32258 —
Integrated Community Oncology Network-Florida Cancer Center Beaches Jacksonville Beach Florida 32250 —
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 —
21st Century Oncology-Orange Park Orange Park Florida 32073 —
UF Cancer Center at Orlando Health Orlando Florida 32806 —
21st Century Oncology-Palatka Palatka Florida 32177 —
Bay Medical Center Panama City Florida 32401 —
Integrated Community Oncology Network-Flager Cancer Center Saint Augustine Florida 32086 —
Tallahassee Memorial HealthCare Tallahassee Florida 32308 —
John B Amos Cancer Center Columbus Georgia 31904 —
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706 —
Northwest Community Hospital Arlington Heights Illinois 60005 —
Northwestern University Chicago Illinois 60611 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Saint John's Hospital Springfield Illinois 62702 —
Parkview Hospital Randallia Fort Wayne Indiana 46805 —
Franciscan Saint Margaret Health-Hammond Campus Hammond Indiana 46320 —
IU Health Methodist Hospital Indianapolis Indiana 46202 —
Finley Hospital Dubuque Iowa 52001 —
Norton Suburban Hospital and Medical Campus Louisville Kentucky 40207 —
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 —
Saint Agnes Hospital Baltimore Maryland 21229 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 —
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Fairview Ridges Hospital Burnsville Minnesota 55337 —
Mercy Hospital Coon Rapids Minnesota 55433 —
Fairview-Southdale Hospital Edina Minnesota 55435 —
Unity Hospital Fridley Minnesota 55432 —
Abbott-Northwestern Hospital Minneapolis Minnesota 55407 —
University of Minnesota/Masonic Cancer Center Minneapolis Minnesota 55455 —
North Memorial Medical Health Center Robbinsdale Minnesota 55422 —
Coborn Cancer Center at Saint Cloud Hospital Saint Cloud Minnesota 56303 —
Saint Cloud Hospital Saint Cloud Minnesota 56303 —
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 —
Park Nicollet Clinic - Saint Louis Park Saint Louis Park Minnesota 55416 —
United Hospital Saint Paul Minnesota 55102 —
Ridgeview Medical Center Waconia Minnesota 55387 —
Saint Louis University Hospital St Louis Missouri 63110 —
Nevada Cancer Research Foundation CCOP Las Vegas Nevada 89106 —
Renown Regional Medical Center Reno Nevada 89502 —
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital New Brunswick New Jersey 08903 —
Riverview Medical Center/Booker Cancer Center Red Bank New Jersey 07701 —
Sparta Cancer Treatment Center Sparta New Jersey 07871 —
University of Rochester Rochester New York 14642 —
Mission Hospital-Memorial Campus Asheville North Carolina 28801 —
Summa Akron City Hospital/Cooper Cancer Center Akron Ohio 44304 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Natalie Warren Bryant Cancer Center at Saint Francis Tulsa Oklahoma 74136 —
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026 —
Radiation Therapy Oncology Group Philadelphia Pennsylvania 19103 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Reading Hospital West Reading Pennsylvania 19611 —
Medical University of South Carolina Charleston South Carolina 29425 —
Thompson Cancer Survival Center Knoxville Tennessee 37916 —
Arlington Cancer Center Arlington Texas 76012 —
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 —
University of Texas Medical Branch Galveston Texas 77555-0565 —
M D Anderson Cancer Center Houston Texas 77030 —
Intermountain Medical Center Murray Utah 84107 —
McKay-Dee Hospital Center Ogden Utah 84403 —
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 —
LDS Hospital Salt Lake City Utah 84143 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 —
Virginia Mason Medical Center Seattle Washington 98101 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —
Froedtert and the Medical College of Wisconsin Milwaukee Wisconsin 53226 —
Wheaton Franciscan Cancer Care - All Saints Racine Wisconsin 53405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00096265, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2018 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00096265 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →